在EGFR驱动的肺腺癌中,息膜巨细胞的新陈代谢和功能支持EGFR信号和生长
Alexandra Kuhlmann-Hogan1, Thekla Cordes2, Ziyan Xu3
1Salk Institute for Biological Studies, La Jolla, CA, United States.
Cancer discovery
|January 19, 2024
概括
新的研究揭示了肺癌细胞如何利用气膜巨细胞获取营养,阻碍免疫疗法. 针对这种途径为EGFR突变肺腺癌提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 免疫疗法对EGFR驱动的肺腺癌 (LUAD) 的疗效有限.
- 了解局部免疫抑制机制对于开发新疗法至关重要.
- 与瘤相关的膜巨细胞 (TA-AMs) 在瘤生长和免疫逃避中发挥作用.
研究的目的:
- 研究TA-AMs支持EGFR驱动的LUAD增长的机制.
- 在LUAD中确定克服免疫疗法耐药性的治疗点.
- 阐明GM-CSF和PPARγ信号在TA-AM功能和LUAD进展中的作用.
主要方法:
- 对表皮分泌物反应中的巨细胞增殖和功能的分析.
- 抑制颗粒细胞 - 巨细胞殖民地刺激因子 (GM-CSF) 和过氧体增殖器激活受体马 (PPARγ) 信号发送.
- 在LUAD细胞中评估胆固醇代谢和EGFR酸化.
- 综合疗法的评估,包括PPARγ抑制和他类药物.
主要成果:
- 增加的表面活性剂和GM-CSF诱导TA-AM增殖,支持LUAD的生长.
- 在TA-AMs中的GM-CSF-PPARγ信号促进胆固醇流向瘤细胞.
- 在TA-AM中抑制气道GM-CSF或PPARγ会损害胆固醇代谢,并抑制LUAD的进展.
- 在TA-AM中对PPARγ的联合阻断和他类药物治疗抑制了瘤进展并增强了抗瘤免疫力.
结论:
- 癌细胞通过GM-CSF-PPARγ信号来代谢地选择TA-AMs来提供营养.
- 这种相互作用促进了EGFR突变LUAD的瘤信号和生长.
- 在TA-AM中准GM-CSF-PPARγ轴是一个有前途的治疗策略,用于免疫治疗耐药的LUAD.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autocrine Signaling
48.1K
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.1K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


